Navigation Links
Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments
Date:10/30/2013

s in the amount of CHF 6.625 million from Abingworth, venBio, Amgen and Aisling, which was part of the investment by these investors in May 2012.

Revenue comprising deferred income from license fees paid by Novartis of CHF 0.25 million has been recognized in the third quarter 2013, unchanged from the third quarter 2012.

Financial summary (IFRS, consolidated)

(in CHF million) Q3 2013 Q3 2012 Revenue 0.3 0.3 Net operating cost (6.0) (4.2) Operating loss (5.8) (3.9) Net loss (7.6) (5.2) Net loss per share (in CHF) (0.34) (0.37) (in CHF million) 30.9.2013 30.6.2013 Cash, cash equivalents & trade and other receivables 15.0 18.1 Full-time equivalents 25.3 24.5

The detailed Q3 Financial Report 2013 can be downloaded at:

http://www.cytos.com/uploads/2013/Cytos_Q_3_2013_EN.pdf

Conference Call to be held on November 5, 2013, 9 a.m. EDT / 15:00 CET

Senior Executive Management will provide an update on recent developments.

The dial-in numbers are:

+41(0)58-310-50-00 (Europe)
+44(0)203-059-58-62 (UK)
+1(1)631-570-5613 (USA)

Please dial-in 10 minutes prior to the call in order to register for the call. The presentation will be available 1 hour prior to the conference call.

Click here to view the presentation.

http://services.choruscall.eu/links/cytos_presenter.html

The conference call will be available as a replay 48 hours after the call.

Please use the following dial-in:

+41(0)91-612-43-30 (Europe)
+44(0)207-108-6233 (UK)
+1(1)866-416-2558 (USA)

Access Code: 13395#


'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cytos Biotechnology Strengthens Management Team
2. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
3. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
4. Puma Biotechnology Announces Completion of Private Placement
5. Animal Biotechnology - Technologies, Markets and Companies
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. JumpStart Invests $250,000 in Milo Biotechnology
9. Global Biotechnology Industry
10. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
11. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Last week, Representatives ... Butterfield (D-NC) took a bold bipartisan step ... introducing the OPEN Act. Original co-sponsors of the ... The Act will incentivize drug makers and innovators ... diseases and pediatric cancers, which opens the door ...
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... announced that Bonnie H. Anderson , president and chief ... the Piper Jaffray 26 th Annual Healthcare Conference on ... New York . The live audio ... website at http://investor.veracyte.com . Please connect to the website ...
(Date:11/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on the ... like its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... US, Europe, Asia, China, Japan etc. regions) industry ...
(Date:11/24/2014)... Senior Vice President, General Manager for Clinical ... acumen Elsevier , a world-leading provider ... congratulates Diane Bartoli , Senior Vice President and ... Solutions, for being recognized in the 13 th ... Profiles in Diversity Journal ® . ...
Breaking Biology Technology:OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 2Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3
... Pharmaceuticals, Inc., a,biotechnology company focused on the development ... Drajeske as Director of Business,Development., Drajeske brings ... the life sciences industry. He formerly served as ... publicly traded biotechnology,company, from 2004 to 2006. While ...
... VELCADE(R) (bortezomib) for Injection sales surpassed $765 ... million in 2007 - - ... myeloma, with launch on track for first half ... MLNM ) today reported 2007 non-GAAP net,income of $86.9 million and GAAP net ...
... Application to be reviewed under European Accelerated ... Pharmion Corporation,(Nasdaq: PHRM ) today ... accepted for review the Company,s Marketing Authorization ... patients with,higher-risk myelodysplastic syndromes (MDS) and announced ...
Cached Biology Technology:Millennium Over-Delivers on 2007 Goals and Financial Guidance 2Millennium Over-Delivers on 2007 Goals and Financial Guidance 3Millennium Over-Delivers on 2007 Goals and Financial Guidance 4Millennium Over-Delivers on 2007 Goals and Financial Guidance 5Millennium Over-Delivers on 2007 Goals and Financial Guidance 6Millennium Over-Delivers on 2007 Goals and Financial Guidance 7Millennium Over-Delivers on 2007 Goals and Financial Guidance 8Millennium Over-Delivers on 2007 Goals and Financial Guidance 9Millennium Over-Delivers on 2007 Goals and Financial Guidance 10Millennium Over-Delivers on 2007 Goals and Financial Guidance 11Millennium Over-Delivers on 2007 Goals and Financial Guidance 12Millennium Over-Delivers on 2007 Goals and Financial Guidance 13Millennium Over-Delivers on 2007 Goals and Financial Guidance 14Millennium Over-Delivers on 2007 Goals and Financial Guidance 15Millennium Over-Delivers on 2007 Goals and Financial Guidance 16Millennium Over-Delivers on 2007 Goals and Financial Guidance 17Millennium Over-Delivers on 2007 Goals and Financial Guidance 18EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 2EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 3EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 4EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 5
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/18/2014)... 2014   News Highlights: ... develop The Partners Data Lake, an agile data ... Lake will allow researcher and clinicians to explore ... the lives of patients , The Partners ... across the Partners system, breaking down physical barriers ...
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... firm, is pleased to announce the promotion of ... Director of Digital Forensics. In Schiff,s new role as ... the team of digital forensics examiners and provide leadership ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... Columbia Engineering and Columbia University Medical Center announced ... bone structure in Chinese-American women to Caucasian women. ... Society,s annual meeting at Long Beach, CA, found ... strength than their Caucasian counterparts, as determined by ...
... kidney is made up of roughly 1 million working units ... the blood, recycle some substances to be reused and eliminate ... called the distal nephron, helps set blood pressure by controlling ... scientists at The University of Texas Health Science Center San ...
... Wild red deer on the Isle of Rum, which were ... the year, a study shows. Scientists believe the annual rutting ... warming spring and summer temperatures. The study shows that the ... on average compared with 30 years ago. The research ...
Cached Biology News:Columbia University uses technological innovation to study bone structure 2Columbia University uses technological innovation to study bone structure 3Warming climate means red deer rutting season arrives early 2
...
Mouse polyclonal antibody raised against a partial recombinant PREB. NCBI Entrez Gene ID = 10113...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
... used to test the crossreactivity of an ... are commonly used as blocking reagents or ... 19 different protein preparations on a nitrocellulose ... species specificity, QC of purified antibodies, selection ...
Biology Products: